Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NCF1 | P14598 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | PLG | P00747 | 1/20 | 0.34 |
| ▸ | PLAT | P00750 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134119 | 0.81 | ALDH1A1 (0.46) | ALDH1A1TDP1KDM1AMAOB | |
| SCHEMBL15040100 | 0.81 | NCF1 (0.44) | NCF1CYP3A4CYP2C9CYP2C19PLG | |
| SCHEMBL27633638 | 0.80 | ALDH1A1 (0.46) | ALDH1A1TDP1 | |
| SCHEMBL25568576 | 0.79 | ALDH1A1 (0.44) | ALDH1A1TDP1KDM1AMAOB | |
| SCHEMBL25568569 | 0.79 | ALDH1A1 (0.44) | ALDH1A1TDP1KDM1AMAOB | |
| Hydrochloric Acid SCHEMBL1784451 | 0.79 | NCF1 (0.42) | NCF1CYP3A4CYP2C9CYP2C19PLG | |
| SCHEMBL19525730 | 0.79 | ALDH1A1 (0.44) | ALDH1A1TDP1KDM1AMAOB | |
| SCHEMBL28419368 | 0.78 | NCF1 (0.40) | NCF1CYP3A4CYP2C9CYP2C19PLG | |
| SCHEMBL25308420 | 0.77 | NCF1 (0.41) | NCF1CYP3A4CYP2C9CYP2C19PLG | |
| SCHEMBL16041810 | 0.77 | NCF1 (0.41) | NCF1CYP3A4CYP2C9CYP2C19PLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117659306-A | Dual-crosslinked acrylic acid secondary fraction, and preparation method and application thereof | 广东恒和永盛集团有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-109415507-B | Thermoplastic polyamide particles | 巴斯夫欧洲公司 | 2022-03-08 | — | — | CN | claimed |
| US-20120244095-A1 | COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS | BASF SE (DE) | 2012-09-27 | — | — | US | claimed |
| CN-100489010-C | Highly branched high-functionality polyureas | BASF AG (DE) | 2009-05-20 | — | — | CN | claimed |
| US-7057003-B2 | Reactive systems, their preparation and their use | BAYER AKTIENGESELLSCHAFT (DE) | 2006-06-06 | — | — | US | claimed |
| US-20040147704-A1 | Reactive systems, their preparation and their use | COVESTRO DEUTSCHLAND AG (DE) | 2004-07-29 | — | — | US | claimed |
| EP-0816326-B1 | Process for preparing mono- and polyspartic acid esters | BAYER AG (DE) | 2000-05-10 | — | — | EP | claimed |
| US-5821326-A | REACTING POLYAMINES WITH UNSATURATED POLYESTERS IN THE PRESENCE OF FIVE-MEMBER NITROGEN HETEROCYCLE CATALYSTS AND USING THE POLYASPARTATE PRODUCTS AS REACTANTS WITH POLYISOCYANATES TO PRODUCE POLYURETHANE COATINGS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-10-13 | — | — | US | claimed |
| EP-0816326-A1 | Process for preparing mono- and polyspartic acid esters | BAYER AG (DE) | 1998-01-07 | — | — | EP | claimed |
| EP-0415213-B1 | Copolymers containing amino groups, process for their preparation and their use as a binder or binder-component | BAYER AG (DE) | 1994-04-13 | — | — | EP | claimed |
| EP-0415213-A2 | Copolymers containing amino groups, process for their preparation and their use as a binder or binder-component | BAYER AG (DE) | 1991-03-06 | — | — | EP | claimed |
| CN-122094998-A | Water-dispersible blocked isocyanate prepolymer systems, process for their preparation and their use | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122095001-A | Blocked isocyanate prepolymer system and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-120025523-A | Blocked isocyanate prepolymer system and preparation method and application thereof | 科思创德国股份有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-120025522-A | Water-dispersible blocked isocyanate prepolymer systems, process for their preparation and their use | 科思创德国股份有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-1144828-C | Polyamines comprising urea groups, method for their production, and their use as hardeners for epoxide resins | — | 2004-04-07 | — | — | CN | disclosed |
| WO-2003066702-A1 | METHOD FOR THE PRODUCTION OF HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-14 | — | — | WO | disclosed |
| CN-1365369-A | Polyamines comprising urea groups, method for their production, and their use as hardeners for epoxide resins | BAYER AG (DE) | 2002-08-21 | — | — | CN | disclosed |
| US-5912386-A | Bridged anthraquinones | BAYER AKTIENGESELLSCHAFT (DE) | 1999-06-15 | — | — | US | disclosed |
| US-5744633-A | Process for the production of diurethanes and their use for the production of diisocyanates | BAYER AKTIENGESELLSCHAFT (DE) | 1998-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120244095-A1 | COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS | PUF60, POLR1C, PICALM | ALDH1A1 4122/4885TDP1 1127/4885NCF1 2351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.